|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs and non-cash interest expense | |||||
| Gain on the sale of assets, net | |||||
| Impairment of assets held for sale | |||||
| Inventory lower of cost or net realizable value adjustment | |||||
| Loss on extinguishment of debt | |||||
| Deferred income taxes | |||||
| Stock-based compensation | |||||
| Loss (income) from equity method investees, net of income taxes | |||||
| Distribution from equity method investees | |||||
| Other | |||||
| Changes in operating assets and liabilities before effects of asset dispositions | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Derivative financial instruments | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Current income taxes | |||||
| Other | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment, net | |||||
| Purchases of marketable securities | |||||
| Proceeds from the sale of marketable securities | |||||
| Proceeds from the sale of assets, net | |||||
| Disposition of equity method investees | |||||
| Proceeds for the sale of equity method investment | |||||
| Investment in equity method investees, net | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of long-term debt | |||||
| Payments of principal on long-term debt | |||||
| Proceeds from short-term borrowings | |||||
| Payments on short-term borrowings | |||||
| Payments on extinguishment of convertible debt | |||||
| Net proceeds from product financing arrangement | |||||
| Payments for repurchase of common stock | |||||
| Payments on extinguishment of non-controlling interest | |||||
| Payments of dividends and distributions | |||||
| Proceeds from issuance of common stock, net | |||||
| Payments of transaction costs | |||||
| Payments of loan fees | |||||
| Payments related to tax withholdings for stock-based compensation | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Net change in cash and cash equivalents, and restricted cash | |||||
| Cash and cash equivalents, and restricted cash, beginning of period | |||||
| Cash and cash equivalents, and restricted cash, end of period | |||||
| Non-cash financing activity | |||||
| Issuance of common stock as a result of the Merger | |||||
| Extinguishment of non-controlling interest within additional paid-in capital | |||||
| Exchange of 4.00% convertible notes due 2024 for shares of common stock held in treasury stock | |||||
| Exchange of 4.125% convertible notes due 2022 for shares of common stock held in treasury stock | |||||
| Cash Flow, Noncash Investing and Financing Activities Disclosure | |||||
| Assets acquired in acquisitions, net of cash | |||||
| Less: noncontrolling interests assumed | |||||
| Net assets acquired | |||||
| Assets disposed of in sale | |||||
| Less: liabilities relinquished | |||||
| Net assets disposed | |||||
| Supplemental disclosures of cash flow | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest | |||||
| Capital expenditures in long-term debt | |||||
| Capital expenditures in accounts payable | |||||
| Capital expenditures in other liabilities | |||||
| Reconciliation of total cash and cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...